{"id":3147,"date":"2024-12-29T13:56:21","date_gmt":"2024-12-29T12:56:21","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/"},"modified":"2024-12-29T13:56:23","modified_gmt":"2024-12-29T12:56:23","slug":"la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/","title":{"rendered":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/fda-approves-tryngolza.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2024\/fda-approves-tryngolza.jpg\" data-sub-html=\"\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>Tryngolza (olezarsen) a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis comme compl\u00e9ment au r\u00e9gime alimentaire pour r\u00e9duire les triglyc\u00e9rides chez les adultes atteints du syndrome de chylomicron\u00e9mie familiale (FCS), qui peut conduire \u00e0 une pancr\u00e9atite aigu\u00eb (PA) potentiellement mortelle, selon un communiqu\u00e9 de presse. communiqu\u00e9 publi\u00e9 par Ionis Pharmaceuticals.<\/p>\n<p>Les donn\u00e9es ont montr\u00e9 que Tryngolza r\u00e9duit de mani\u00e8re significative et substantielle les taux de triglyc\u00e9rides chez les adultes atteints de FCS et r\u00e9duit les \u00e9v\u00e9nements AP lorsqu&rsquo;il est utilis\u00e9 avec un r\u00e9gime comprenant \u2264 20 g de graisses par jour. Tryngolza est auto-administr\u00e9 une fois par mois via un auto-injecteur.<\/p>\n<p>L&rsquo;approbation de la FDA \u00e9tait bas\u00e9e sur les donn\u00e9es de l&rsquo;essai clinique mondial de phase 3 Balance, multicentrique, randomis\u00e9 et contr\u00f4l\u00e9 par placebo, impliquant des adultes pr\u00e9sentant un FCS g\u00e9n\u00e9tiquement identifi\u00e9 et des taux de triglyc\u00e9rides \u00e0 jeun \u2265 880 mg\/dL. Entre le d\u00e9but et six mois, il y a eu une r\u00e9duction moyenne significative, ajust\u00e9e au placebo, des taux de triglyc\u00e9rides de 42,5 pour cent. Entre le d\u00e9but et 12 mois, les r\u00e9ductions ont \u00e9t\u00e9 encore am\u00e9lior\u00e9es, avec une r\u00e9duction moyenne des triglyc\u00e9rides de 57 pour cent, ajust\u00e9e au placebo. Sur 12 mois, il y a eu une r\u00e9duction cliniquement significative des \u00e9v\u00e9nements AP\u00a0; un patient (5 pour cent) a connu un \u00e9v\u00e9nement AP dans le groupe Tryngolza, contre sept (30 pour cent) qui ont connu 11 \u00e9pisodes dans le groupe placebo. Un profil de s\u00e9curit\u00e9 favorable a \u00e9t\u00e9 observ\u00e9 pour Tryngolza.<\/p>\n<p>\u00ab\u00a0Pour la premi\u00e8re fois, les adultes atteints de FCS peuvent d\u00e9sormais acc\u00e9der \u00e0 un traitement qui r\u00e9duit consid\u00e9rablement les triglyc\u00e9rides et le risque de pancr\u00e9atite aigu\u00eb d\u00e9bilitante et potentiellement mortelle\u00a0\u00bb, a d\u00e9clar\u00e9 Brett P. Monia, Ph.D., PDG d&rsquo;Ionis. dans une d\u00e9claration.<\/p>\n<p>L&rsquo;approbation de Tryngolza a \u00e9t\u00e9 accord\u00e9e \u00e0 Ionis Pharmaceuticals.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tryngolza (olezarsen) a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis comme compl\u00e9ment<\/p>\n","protected":false},"author":1,"featured_media":3148,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[858,321,3293,1674,3292,3294,447,8,2164,283,3291],"class_list":["post-3147","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-alimentaire","tag-approuve","tag-chylomicronemie","tag-comme","tag-complement","tag-familiale","tag-fda","tag-pour","tag-regime","tag-syndrome","tag-tryngolza","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"Tryngolza (olezarsen) a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis comme compl\u00e9ment\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-29T12:56:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-29T12:56:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale\",\"datePublished\":\"2024-12-29T12:56:21+00:00\",\"dateModified\":\"2024-12-29T12:56:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\"},\"wordCount\":351,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg\",\"keywords\":[\"alimentaire\",\"approuve\",\"chylomicron\u00e9mie\",\"comme\",\"compl\u00e9ment\",\"familiale\",\"FDA\",\"pour\",\"r\u00e9gime\",\"syndrome\",\"Tryngolza\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\",\"name\":\"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg\",\"datePublished\":\"2024-12-29T12:56:21+00:00\",\"dateModified\":\"2024-12-29T12:56:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg\",\"width\":1280,\"height\":853,\"caption\":\"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org","og_description":"Tryngolza (olezarsen) a \u00e9t\u00e9 approuv\u00e9 par la Food and Drug Administration des \u00c9tats-Unis comme compl\u00e9ment","og_url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/","og_site_name":"RVH-Synergie","article_published_time":"2024-12-29T12:56:21+00:00","article_modified_time":"2024-12-29T12:56:23+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale","datePublished":"2024-12-29T12:56:21+00:00","dateModified":"2024-12-29T12:56:23+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/"},"wordCount":351,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg","keywords":["alimentaire","approuve","chylomicron\u00e9mie","comme","compl\u00e9ment","familiale","FDA","pour","r\u00e9gime","syndrome","Tryngolza"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/","url":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/","name":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg","datePublished":"2024-12-29T12:56:21+00:00","dateModified":"2024-12-29T12:56:23+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/12\/1735476981_La-FDA-approuve-Tryngolza-comme-complement-au-regime-alimentaire-pour.jpg","width":1280,"height":853,"caption":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/la-fda-approuve-tryngolza-comme-complement-au-regime-alimentaire-pour-le-syndrome-de-chylomicronemie-familiale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"La FDA approuve Tryngolza comme compl\u00e9ment au r\u00e9gime alimentaire pour le syndrome de chylomicron\u00e9mie familiale"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=3147"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/3147\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/3148"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=3147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=3147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=3147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}